Endocrine disorders are a relatively common accompaniment of polyostotic fibrous dysplasia. Considerable debate has taken place concerning possible responsible mechanisms. This case demonstrates that the hyperthyroidism associated with the condition is of thyroidal origin and of probable autoimmune aetiology.
AlbrightF, ButlerAM, HamptonAO, SmithP.Syndrome characterised by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. New Engl J Med, 1937; 216: 727–746.
2.
McCuneDJ, BruchH.Osteodystrophia fibrosa. Report of a case in which the condition was combined with precocious puberty, pathological pigmentation of the skin and hyperthyroidism with a review of the literature. Am J Dis Child, 1937; 54: 806–848.
3.
HallR, WarwickC.Hypersecretion of hypothalamic releasing hormones; a possible explanation of the endocrine manifestations of polyostotic fibrous dysplasia (Albright's Syndrome). Lancet1972; 1; 1313–1317.
4.
WilsonR.McKillopJH, PearsonDW, CuthbertGF, ThomsonJA. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and thyroid stimulating hormone receptor antibody levels. J Nucl Med1985; 26; 1024–1028.
5.
O'ReillyD St. J, FraserWD, PennyMDArginine infusion blocks the action of parathyroid hormone but not arginine vasopressin on the renal tubule in man. J Endocrinol1986, 111; 501–506.
6.
ChungKF, Alaghband-ZadekJ, GuzA.Acromegaly and hyperprolactinaemia in McCune-Albright Syndrome. Am J Dis Child;1983137; 134–136.
7.
LightnerES, PennyR, FrasierSD. Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome); evidence for abnormal hypothalamic function. J Paediat197587; 922–927.
8.
CarrD, MathieJK, MalinersAR. Hyperprolactinaemia in a patient with the McCune-Albright syndrome. Br J Obst Gynaecol1979; 86330–331.
